Insider · CIK 0001590102
Anand Mehra
Files at ACRS (Aclaris Therapeutics, Inc.). First filing Nov 20, 2024, latest Nov 20, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ACRS: Aclaris Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | ACRSbuy Aclaris Therapeutics, Inc. | $1.5M 666,666 shares | +1537% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 6, 2025 | ACRS Aclaris Therapeutics, Inc. | MOption exercise Common Stock | +4,793 | - | - | 714,823 | Jun 9, 2025 |
| Jun 5, 2025 | ACRS Aclaris Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +42,350 | $0.00 | $0 | 42,350 | Jun 9, 2025 |
| Jun 5, 2025 | ACRS Aclaris Therapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +11,580 | $0.00 | $0 | 11,580 | Jun 9, 2025 |
| Jun 6, 2025 | ACRS Aclaris Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -4,793 | $0.00 | $0 | 0 | Jun 9, 2025 |
| Nov 19, 2024 | ACRS Aclaris Therapeutics, Inc. | POpen-market purchase Common Stock | +666,666 | $2.25 | $1.5M | 710,030 | Nov 20, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.